Theratechnologies Inc (TH) Set to Announce Quarterly Earnings on Thursday
Theratechnologies Inc (TSE:TH) is scheduled to be releasing its earnings data before the market opens on Thursday, October 5th. Analysts expect Theratechnologies to post earnings of C($0.02) per share for the quarter.
Theratechnologies Inc (TH) opened at 7.59 on Tuesday. Theratechnologies Inc has a 12-month low of $2.61 and a 12-month high of $8.72. The firm’s market capitalization is $564.81 million. The firm has a 50 day moving average of $7.52 and a 200 day moving average of $7.14.
TH has been the topic of several research analyst reports. Scotiabank reiterated an “outperform” rating and issued a C$9.50 price objective on shares of Theratechnologies in a research note on Wednesday, June 21st. National Bank Financial lowered Theratechnologies from an “outperform market weight” rating to a “sector perform market weight” rating in a report on Monday, July 3rd.
TRADEMARK VIOLATION NOTICE: “Theratechnologies Inc (TH) Set to Announce Quarterly Earnings on Thursday” was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright legislation. The correct version of this report can be viewed at https://www.thecerbatgem.com/2017/10/03/theratechnologies-inc-th-set-to-announce-quarterly-earnings-on-thursday.html.
Theratechnologies Inc is a specialty pharmaceutical company. The Company addresses medical needs to promote healthy living among human immunodeficiency virus (HIV) patients. Its products include EGRIFTA and Ibalizumab. EGRIFTA (tesamorelin for injection) refers to tesamorelin and it is indicated for the reduction of excess abdominal fat in HIV infected patients with lipodystrophy.
Receive News & Stock Ratings for Theratechnologies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies Inc and related stocks with our FREE daily email newsletter.